Low Dose Ruxolitinib in Indian Haplo-Identical Transplant Patients with Steroid Refractory Acute Graft Versus Host Disease

被引：0
|
作者：
Kumar, Kishore [1 ]
Prabhu, Durai [2 ]
Kandan, Mani [3 ]
Thooran, Sen [3 ]
Subash, Chezhian [1 ]
机构：
[1] MIOT Inst Haematol, Chennai, Tamil Nadu, India
[2] MIOT Int Hosp, Chennai, Tamil Nadu, India
[3] MIOT, Chennai, Tamil Nadu, India
来源：
BLOOD | 2022年 / 140卷
关键词：
D O I：
10.1182/blood-2022-157269
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：12893 / 12894
页数：2
相关论文
共 50 条
  • [41] Real-world data on ruxolitinib in steroid-refractory acute intestinal graft-versus-host-disease
    Biavasco, F.
    Ihorst, G.
    Waesch, R.
    Wehr, C.
    Bertz, H.
    Finke, J.
    Zeiser, R.
    BONE MARROW TRANSPLANTATION, 2022, 57 (SUPPL 1) : 184 - 185
  • [42] Sequential haplo-identical conditioning transplant regimen for pediatric patients with relapsed or refractory hemophagocytic lymphohistiocytosis
    Yue, Yan
    Fan, Shifen
    Liu, Zhouyang
    Jiang, Fan
    Chen, Jiao
    Qin, Jiayue
    Sun, Yuan
    BONE MARROW TRANSPLANTATION, 2024, 59 (04) : 513 - 517
  • [43] Conventional Versus Low Dose Rituximab in the Treatment of Steroid-Refractory Chronic Graft Versus Host Disease
    Rummage, Claire W.
    Watts, Nicole
    McGwin, Gerald
    Saad, Ayman
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (03) : S203 - S204
  • [44] Ruxolitinib in Glucocorticoid Refractory Chronic Graft versus Host Disease
    Sharma, Aparna
    Sharma, Vibhor
    INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2021, 42 (06) : 582 - 583
  • [45] Ruxolitinib: a potential treatment for corticosteroid refractory acute graft-versus-host disease
    Abedin, Sameem M.
    Hamadani, Mehdi
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2020, 29 (05) : 423 - 427
  • [46] The development of ruxolitinib for glucocorticoid-refractory acute graft-versus-host disease
    Zeiser, Robert
    Socie, Gerard
    BLOOD ADVANCES, 2020, 4 (15) : 3789 - 3794
  • [47] Efficacy of low-dose Ruxolitinib as Savage Therapy in Heavily Pretreated Patients with Moderate/severe steroid-refractory Chronic graft-versus-host Disease
    Zhao, Yanmin
    Shi, Jimin
    Luo, Yi
    Tan, Yamin
    Yu, Jian
    Fu, Huarui
    Lai, Xiaoyu
    Huang, He
    BONE MARROW TRANSPLANTATION, 2020, 55 (SUPPL 1) : 344 - 344
  • [48] Ruxolitinib for Acute Graft-versus-Host Disease
    Gratwohl, Alois
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (05): : 501 - 501
  • [49] Ex vivo T-cell depletion for graft versus host disease prophylaxis in related haplo-identical allogeneic stem cell transplant recipients.
    McGuirk, JP
    Dix, SP
    Greenfield, D
    Belt, RJ
    Picken, S
    Meagher, R
    Jensen, K
    Barnhart, CS
    Gilman, A
    BLOOD, 2000, 96 (11) : 362B - 363B
  • [50] Low-dose rituximab in steroid-refractory chronic graft-versus-host disease
    Colunga-Pedraza, Perla R.
    Barbosa-Castillo, Luz Maria
    Coronado-Alejandro, Edgar Ulises
    Vaquera-Alfaro, Hector Alejandro
    Lopez-Reyna, Ingrid Gabriela
    Colunga-Pedraza, Julia E.
    Gomez-Almaguer, David
    TRANSPLANT IMMUNOLOGY, 2023, 81
12345